Mood stabiliser
Pregnancy: Ebstein's anomaly risk (smaller than historically thought). Use only if essential in first trimester; monitor levels closely throughout.
Lithium Carbonate
Brand names: Priadel, Camcolit
Adult dose
Dose: Start 200–400 mg once daily at night; titrate by serum levels to target 0.6–1.0 mmol/L
Route: Oral
Frequency: Once or twice daily (modified-release: once daily)
Max: Guided by serum levels (target 0.6–1.0 mmol/L); higher in acute mania (0.8–1.2)
Start 200–400 mg at night. Adjust every 5–7 days by serum level (12h post-dose). Maintenance: 0.6–0.8 mmol/L. Acute mania: 0.8–1.2 mmol/L. Switch between preparations (Priadel vs Camcolit) requires retitration. Adequate sodium and fluid intake essential.
Paediatric dose
Route: Oral
Frequency: Once daily at night
Max: Guided by serum level (0.6–1.0 mmol/L)
Not licensed in children <12 years. 12–17 years (specialist only): starting doses lower; 150–200 mg at night, titrate by levels. Serum levels same targets as adults.
Dose adjustments
Renal
CONTRAINDICATED in significant renal impairment. Use extreme caution if mild renal impairment — reduced excretion causes toxicity. Specialist input essential.
Hepatic
Lithium not hepatically metabolised; no hepatic dose adjustment required.
Clinical pearls
- Narrow therapeutic index — 12-hour post-dose serum levels essential (toxicity at >1.5 mmol/L)
- Patient must carry lithium card and blue lithium alert card
- Any illness causing dehydration or sodium loss can cause lithium toxicity — patient education
- Avoid NSAIDs and ACE inhibitors if possible — use paracetamol for analgesia
- Check TFTs and eGFR every 6 months (hypothyroidism and nephropathy)
Contraindications
- Renal impairment (significant)
- Untreated hypothyroidism
- Addison's disease
- Brugada syndrome
- Dehydration states
Side effects
- Fine tremor
- Polyuria and polydipsia (nephrogenic diabetes insipidus)
- Hypothyroidism (long-term — 20–40% on long-term therapy)
- Weight gain
- GI upset (nausea, diarrhoea — more at start)
- Cognitive dulling
- Toxicity signs: coarse tremor, confusion, ataxia, seizures (levels >1.5 mmol/L)
Interactions
- NSAIDs — significantly increase lithium levels (avoid; use paracetamol)
- ACE inhibitors/ARBs/thiazide diuretics — increase lithium levels (reduce sodium and volume)
- Loop diuretics (furosemide) — increase lithium levels
- Sodium depletion (vomiting, diarrhoea, hot weather) — increases lithium levels
- SSRIs/serotonergic agents — increased serotonin syndrome risk
Monitoring
- Serum lithium level (12h post-dose, every 3–6 months when stable)
- eGFR (6-monthly)
- TFTs (6-monthly)
- Weight
- U&E
Reference: BNFc; BNF; NICE NG185 Bipolar; NICE NG66 Prescribing Lithium. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185 / BNF